Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Typhoid Antibody Testing Market Forecast Highlighting Growth From $9.1 Billion To $11.86 Billion
The market for typhoid antibody testing has experienced robust expansion, projected to increase from $8.45 billion in 2025 to $9.1 billion in 2026, reflecting a compound annual growth rate of 7.8%. This historical upward trend is largely attributable to an escalating incidence of typhoid fever in regions where it is endemic, the broader implementation of public health screening initiatives, enhanced accessibility of serological diagnostic techniques, the proliferation of diagnostic laboratory capabilities, and a heightened consciousness regarding the management of infectious diseases.
The market for typhoid antibody testing is poised for substantial expansion, projected to reach $11.87 billion by 2030, reflecting a compound annual growth rate of 6.9%. This anticipated growth over the forecast period is driven by several key factors, including a surging need for swift and precise diagnostic solutions, the proliferation of testing capabilities outside traditional laboratory settings, increased financial backing for cutting-edge immunoassay advancements, a heightened emphasis on readiness for disease outbreaks, and a growing embrace of digital laboratory infrastructure. Furthermore, significant trends shaping this market during the forecast years encompass a greater utilization of rapid diagnostic test kits, a mounting demand for point-of-care typhoid diagnostic tools, expanded application of ELISA-based assays, wider deployment of laboratory automation in diagnostic processes, and an intensified concentration on detecting the disease in its early stages.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16815&type=smp
Typhoid Antibody Testing Market Growth Drivers And Industry Catalysts
The increasing prevalence of diseases transmitted through water is anticipated to be a significant catalyst for the expansion of the typhoid antibody testing market. These waterborne illnesses, stemming from harmful microbes present in contaminated water sources, are frequently exacerbated by inadequate sanitation and hygiene practices, limited access to potable water, burgeoning urbanization, climatic shifts, and agricultural discharge into waterways. Typhoid antibody testing plays a crucial role in addressing this trend by facilitating prompt diagnosis, confirming infection, and assessing treatment effectiveness, which in turn assists in identifying individuals who carry the typhoid fever pathogen and aids in implementing strategies to prevent further waterborne infections. For example, data from the Coalition against Typhoid, a US-based entity focused on averting typhoid and related invasive salmonellosis, revealed that the Philippines documented 4,440 instances of typhoid between January 1 and April 15, 2023. This figure represents a substantial 77% surge when contrasted with the corresponding timeframe in 2022, underscoring the direct correlation between the escalation of waterborne disease incidents and the heightened demand within the typhoid antibody testing sector.
Typhoid Antibody Testing Market Segment Landscape: Which Areas Lead Market Development?
The typhoid antibody testing market covered in this report is segmented –
1) By Product Type: Rapid Serological Tests, Hem-agglutination And Co-agglutination, Counter Immunoelectrophoresis, Typhidot Test, Widal Test
2) By Paratyphi Type: Paratyphi A, Paratyphi B, Paratyphi C
3) By End-User: Hospitals, Serological Testing Centers, Clinics, Diagnostic Centers, Other End Users
Subsegments:
1) By Rapid Serological Tests: Lateral Flow Immunoassays (LFIA), Immunochromatographic Tests (ICT), Enzyme-Linked Immunosorbent Assays (ELISA)
2) By Hem-agglutination And Co-agglutination: Hemagglutination Assay, Co-agglutination Assay
3) By Counter Immunoelectrophoresis: Gel-Based Counter Immunoelectrophoresis, Paper-Based Counter Immunoelectrophoresis
4) By Typhidot Test: Typhidot-M (IgM) Test, Typhidot-G (IgG) Test
5) By Widal Test: Tube Widal Test, Slide Widal Test
#Typhoid Antibody Testing Market Trends Influencing Long-Term Demand
The typhoid antibody testing market is experiencing a strong push from leading enterprises toward the creation of pioneering solutions, specifically molecular diagnostic tests, aimed at improving both the precision and swiftness of diagnosing typhoid fever. These molecular diagnostic tests boast elevated levels of sensitivity and specificity, thereby enabling precise and prompt identification of causative agents such as Salmonella Typhi in individuals suspected of having typhoid fever. To illustrate, in April of 2023, Vanguard Diagnostics, a company based in India specializing in diagnostic reagents, introduced the VANSCAN typhoid RT PCR test, a molecular diagnostic test leveraging its proprietary technology. This test is engineered for the detection and diagnosis of typhoid fever utilizing a real-time PCR (RT-PCR) testing methodology, which surpasses traditional serological tests in accuracy and sensitivity. The VANSCAN Typhoid RT PCR Test represents a considerable leap forward in how typhoid is diagnosed, setting a new benchmark for early, precise, and dependable disease identification within India and on a worldwide scale.
Typhoid Antibody Testing Market Industry Leaders And Market Competition
Major companies operating in the typhoid antibody testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Sekisui Diagnostics, CTK Biotech Inc., Creative Diagnostics, Fortress Diagnostics Ltd., CerTest Biotec S.L, InBios International Inc., J. Mitra & Co. Pvt. Ltd, AccuBioTech Co. Ltd, Vanguard Diagnostics Pvt. Ltd., Suburban Diagnostics India Private Limited, Biorex Diagnostics, Genebio Healthcare Private Limited, ICT Diagnostics
Access The Complete Typhoid Antibody Testing Market Report:
https://www.thebusinessresearchcompany.com/report/typhoid-antibody-testing-global-market-report
Typhoid Antibody Testing Market Geographic Analysis: Where Is Demand Growing The Fastest?
Asia-Pacificwas the largest region in the typhoid antibody testing market in 2025. The regions covered in the typhoid antibody testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
